Keyword: branded drugs

News

Generics Brought Down Common Drug Prices in 2012

05.03.2013 - Cheaper generic drugs in 2012 brought down spending on treatments for common diseases like high cholesterol for the first time in 20 years, according to a report from the largest...

News

AbbVie Forecasts Slower Humira Growth

31.01.2013 - AbbVie, the pharmaceuticals business spun off earlier this month by Abbott Laboratories, forecast 2013 earnings in line with Wall Street forecasts but slowing sales growth for...

News

Top EU Court Upholds AstraZeneca Fine Over Ulcer Drug

06.12.2012 - The European Union's highest court has upheld a €52.5 million ($69 million) antitrust fine levied against AstraZeneca for blocking the entry of cheaper rivals to its then...

News

Abbott Q3 Profit Tops View

17.10.2012 - Abbott Laboratories reported mixed quarterly results, with earnings topping estimates but sales missing expectations as growth slowed for its Humira arthritis drug and other...

News

EU to Charge Servier, Lundbeck over Generics

25.07.2012 - EU antitrust regulators are to charge French drugmaker Servier and Danish peer Lundbeck in two separate cases this week related to blocking the entry of cheaper generic medicines...

News

Generics Seen Cutting into Drug Sales Growth through 2016

12.07.2012 - Annual global spending on prescription drugs will rise 25% by 2016 to $1.2 trillion, as surging growth in emerging markets eclipses weak gains in developed markets like the United...

News

India to Give Free Generic Drugs to Hundreds of Millions

05.07.2012 - India has put in place a $5.4 billion policy to provide free medicine to its people, a decision that could change the lives of hundreds of millions, but a ban on branded drugs...